TransMedics Group, Inc. — Director's Dealing 2025

Feb 27, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2025-02-24

Reporting Person: Corcoran Nicholas (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-24	Common Stock	A	12676	—	Acquired	33781	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-24	Stock Option (Right to Buy)	$77.12	A	19079	Acquired	2035-02-24	Common Stock (19079)	Direct

Footnotes

F1: Consists of 12,676 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2: The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.